糖尿病、母体肥胖及胰岛素依赖型妊娠期糖尿病与妊娠期COVID-19相关:INTERCOVID研究
INTERCOVID是一项2020年3月至2021年2月在18国43家机构开展的多国研究,纳入2184名孕妇,2071名纳入分析。结果显示,孕前糖尿病(RR 1.94)、超重或肥胖(RR 1.20)与COVID-19诊断相关,胰岛素依赖型妊娠期糖尿病亦相关(正常体重RR 1.79,超重或肥胖RR 1.77)。作者认为这些合并症孕妇应接种疫苗。
要点
- 孕前糖尿病与COVID-19诊断相关,风险比1.94(95%CI 1.55-2.42)。
- 超重或肥胖(BMI≥25 kg/m2)与COVID-19诊断相关,风险比1.20(95%CI 1.06-1.37)。
- 胰岛素依赖型妊娠期糖尿病与COVID-19相关,正常体重者风险比1.79,超重或肥胖者1.77。
核心结论
- 糖尿病和超重或肥胖是妊娠期COVID-19诊断的危险因素,胰岛素依赖型妊娠期糖尿病与该病相关。
- 作者认为这些合并症孕妇接种疫苗至关重要。
研究设计与样本
- INTERCOVID为多国研究,2020年3月至2021年2月在18个国家43家机构开展,纳入2184名年龄≥18岁孕妇,2071名纳入分析。
- 每名COVID-19确诊孕妇匹配2名同机构未确诊孕妇(分娩或启动产前保健),采用广义线性模型(泊松分布、对数链接、稳健标准误)评估暴露与COVID-19诊断的关系。
- 暴露包括孕前糖尿病、高体重指数(超重或肥胖定义为BMI≥25 kg/m2)和妊娠期糖尿病;主要结局为妊娠期或分娩时任何时间基于实时聚合酶链反应、抗原检测、抗体检测、影像学肺部表现或≥2项预设COVID-19症状的COVID-19确诊。
主要发现
- COVID-19与孕前糖尿病相关(风险比1.94;95%CI 1.55-2.42),与超重或肥胖相关(风险比1.20;95%CI 1.06-1.37),与妊娠期糖尿病相关(风险比1.21;95%CI 0.99-1.46)。
- 妊娠期糖尿病关联特异性见于需要胰岛素者:正常体重者风险比1.79(95%CI 1.06-3.01),超重或肥胖者风险比1.77(95%CI 1.28-2.45)。
- 孕前糖尿病与COVID-19诊断的关联略强:正常体重者风险比1.93(95%CI 1.18-3.17),超重或肥胖者风险比2.32(95%CI 1.82-2.97)。
- 限制于分娩前一周或整个孕期有实时聚合酶链反应或抗原检测者、多重插补缺失变量或控制入组月份后,观察到的关联相似。
临床怎么用
- 作者认为,患有糖尿病和超重或肥胖等合并症的孕妇接种疫苗至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Among nonpregnant individuals, diabetes mellitus and high body mass index increase the risk of COVID-19 and its severity. OBJECTIVE: This study aimed to determine whether diabetes mellitus and high body mass index are risk factors for COVID-19 in pregnancy and whether gestational diabetes mellitus is associated with COVID-19 diagnosis. STUDY DESIGN: INTERCOVID was a multinational study conducted between March 2020 and February 2021 in 43 institutions from 18 countries, enrolling 2184 pregnant women aged ≥18 years; a total of 2071 women were included in the analyses. For each woman diagnosed with COVID-19, 2 nondiagnosed women delivering or initiating antenatal care at the same institution were also enrolled. The main exposures were preexisting diabetes mellitus, high body mass index (overweight or obesity was defined as a body mass index ≥25 kg/m2), and gestational diabetes mellitus in pregnancy. The main outcome was a confirmed diagnosis of COVID-19 based on a real-time polymerase chain reaction test, antigen test, antibody test, radiological pulmonary findings, or ≥2 predefined COVID-19 symptoms at any time during pregnancy or delivery. Relationships of exposures and COVID-19 diagnosis were assessed using generalized linear models with a Poisson distribution and log link function, with robust standard errors to account for model misspecification. Furthermore, we conducted sensitivity analyses: (1) restricted to those with a real-time polymerase chain reaction test or an antigen test in the last week of pregnancy, (2) restricted to those with a real-time polymerase chain reaction test or an antigen test during the entire pregnancy, (3) generating values for missing data using multiple imputation, and (4) analyses controlling for month of enrollment. In addition, among women who were diagnosed with COVID-19, we examined whether having gestational diabetes mellitus, diabetes mellitus, or high body mass index increased the risk of having symptomatic vs asymptomatic COVID-19. RESULTS: COVID-19 was associated with preexisting diabetes mellitus (risk ratio, 1.94; 95% confidence interval, 1.55-2.42), overweight or obesity (risk ratio, 1.20; 95% confidence interval, 1.06-1.37), and gestational diabetes mellitus (risk ratio, 1.21; 95% confidence interval, 0.99-1.46). The gestational diabetes mellitus association was specifically among women requiring insulin, whether they were of normal weight (risk ratio, 1.79; 95% confidence interval, 1.06-3.01) or overweight or obese (risk ratio, 1.77; 95% confidence interval, 1.28-2.45). A somewhat stronger association with COVID-19 diagnosis was observed among women with preexisting diabetes mellitus, whether they were of normal weight (risk ratio, 1.93; 95% confidence interval, 1.18-3.17) or overweight or obese (risk ratio, 2.32; 95% confidence interval, 1.82-2.97). When the sample was restricted to those with a real-time polymerase chain reaction test or an antigen test in the week before delivery or during the entire pregnancy, including missing variables using imputation or controlling for month of enrollment, the observed associations were comparable. CONCLUSION: Diabetes mellitus and overweight or obesity were risk factors for COVID-19 diagnosis in pregnancy, and insulin-dependent gestational diabetes mellitus was associated with the disease. Therefore, it is essential that women with these comorbidities are vaccinated.
引用
- Eskenazi B, Rauch S, Iurlaro E, et al. Diabetes mellitus, maternal adiposity, and insulin-dependent gestational diabetes are associated with COVID-19 in pregnancy: the INTERCOVID study. Am J Obstet Gynecol. 2021. PMID: 34942154. doi:10.1016/j.ajog.2021.12.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。